Earnings History Data for Shattuck Labs, Inc. (STTK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Shattuck Labs, Inc.

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North Carolina and Austin, Texas. Shattuck Labs Inc. is based in Austin, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-08-2024	AH		STTK	Shattuck Labs	195.00	-0.42	-0.41	0.00	Shattuck Labs GAAP EPS of -$0.42, revenue of $1.61M [8/2/2024 10:32 AM]	3.66	-0.11 (-2.92%)	3.95	0.18 (4.77%)	1.33 - 11.76	201,724	240,000	7,312
Shattuck Labs GAAP EPS of -$0.42, revenue of $1.61M [8/2/2024 10:32 AM]
02-05-2024	PM		STTK	Shattuck Labs	498.00	-0.37	-0.47	0.00	Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M [5/2/2024 8:05 AM]	11.11	0.25 (2.30%)	0.0	0.0 (0.00%)	1.33 - 11.58	233,900	330,000	0
Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M [5/2/2024 8:05 AM]
09-11-2023	PM		STTK	Shattuck Labs, Inc.	93.44	-0.65	-0.51	-0.58	Shattuck Labs GAAP EPS of -$0.65 misses by $0.14, revenue of $0.69M beats by $0.52M [11/9/2023 7:00 AM]	1.82	-0.55 (-23.21%)	2.30	-0.07 (-2.95%)	1.33 - 4.76	37,122	100,000	401
Shattuck Labs GAAP EPS of -$0.65 misses by $0.14, revenue of $0.69M beats by $0.52M [11/9/2023 7:00 AM]
09-05-2023	AH		STTK	Shattuck Labs	115.00	-0.49	-0.61	0.00	Shattuck Labs GAAP EPS of -$0.49 beats by $0.15, revenue of $0.06M misses by $0.03M [5/10/2023 1:20 PM]	2.71	-0.14 (-4.91%)	0.0	0.0 (0.00%)	1.85 - 5.82	49,357	30,000	0
Shattuck Labs GAAP EPS of -$0.49 beats by $0.15, revenue of $0.06M misses by $0.03M [5/10/2023 1:20 PM]
23-02-2023	AH	4:30 PM ET (Feb 23)	STTK	Shattuck Labs, Inc.	183.55	-0.60	-0.62	0.18	Shattuck Labs GAAP EPS of -$0.60 beats by $0.03, revenue of $0.39M beats by $0.37M [2/23/2023 6:41 PM]	4.55	0.01 (0.22%)	4.60	0.06 (1.32%)	1.85 - 5.82	28,089	20,000	200
Shattuck Labs GAAP EPS of -$0.60 beats by $0.03, revenue of $0.39M beats by $0.37M [2/23/2023 6:41 PM]
08-11-2022	AH	4:30 PM ET (Nov 8)	STTK	Shattuck Labs, Inc.	109.35	-0.58	-0.68	-0.41	Shattuck Labs GAAP EPS of -$0.58 beats by $0.09, revenue of $0.2M [11/8/2022 5:05 PM]	2.07	-0.14 (-6.33%)	2.21	0.0 (0.00%)	2.05 - 19.00	136,075	70,000	2,660
Shattuck Labs GAAP EPS of -$0.58 beats by $0.09, revenue of $0.2M [11/8/2022 5:05 PM] Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights [Nov-08-22 04:30PM] Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting [Nov-07-22 08:00AM]
11-08-2022	PM		STTK	Shattuck Labs, Inc.	193.25	-0.65	-0.61	-0.56	Shattuck Labs GAAP EPS of -$0.65 misses by $0.06 [8/11/2022 9:09 AM]	3.76	-0.21 (-5.29%)	0.0	0.0 (0.00%)	3.68 - 12.42	14,481	20,000	0
Shattuck Labs GAAP EPS of -$0.65 misses by $0.06 [8/11/2022 9:09 AM] Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights [Aug-11-22 07:00AM]
12-05-2022	PM		STTK	Shattuck Labs	156.00	-0.58	-0.55	0.00	Shattuck Labs GAAP EPS of -$0.58 [5/12/2022 8:21 AM]	3.53	0.27 (8.28%)	0.0	0.0 (0.00%)	3.20 - 31.23	108,538	250,000	0
Shattuck Labs GAAP EPS of -$0.58 [5/12/2022 8:21 AM] Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights [May-12-22 07:00AM]
15-03-2022	PM	8:00 AM ET (Mar 15)	STTK	Shattuck Labs	190.00	0.18	-0.43	0.00	Shattuck Labs GAAP EPS of $0.18, revenue of $30.08M [3/15/2022 7:49 AM]	4.41	0.12 (2.80%)	0.0	0.0 (0.00%)	4.22 - 40.92	123,525	198,385	0
Shattuck Labs GAAP EPS of $0.18, revenue of $30.08M [3/15/2022 7:49 AM] Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights [Mar-15-22 07:00AM]
09-11-2021	PM		STTK	Shattuck Labs	778.00	-0.41	-0.44	0.00	Shattuck Labs EPS beats by $0.03, misses on revenue [11/9/2021 8:49 AM]	13.58	-5.46 (-28.67%)	19.04	0.0 (0.00%)	13.34 - 60.52	1,097,238	110,000	115
Shattuck Labs EPS beats by $0.03, misses on revenue [11/9/2021 8:49 AM] Shattuck Labs falls 28% following Q3 2021 earnings misses [11/9/2021 2:12 PM] Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights [Nov-09-21 08:00AM] Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252 [Nov-09-21 08:00AM] Takeda, Shattuck Labs Terminate Immuno-Oncology Pact [Nov-09-21 01:19PM]
11-08-2021	AH	4:45 PM ET (Aug 11)	STTK	Shattuck Labs, Inc.	859.88	-0.56	-0.34	0.00	Shattuck Labs reports Q2 results [8/11/2021 4:55 PM]	20.56	0.51 (2.54%)	23.00	2.95 (14.71%)	17.51 - 60.52	86,891	80,000	2,090
Shattuck Labs reports Q2 results [8/11/2021 4:55 PM] Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252 [Aug-11-21 04:30PM]